Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
The trial is conducted in Europe and Africa. The aim of the trial is to compare the use of
insulin detemir twice daily combined with mealtime insulin aspart against that of insulin
glargine once daily combined with mealtime insulin aspart. The trial involves patients with
Type 1 Diabetes.